October 24, 2022
PET/MR imaging in preoperative planning for epilepsy surgery
Manjari Murthy, Director of Product Management Epilepsy is a neurological disorder that affects 4 million people in North America (CDC, Canada.ca), 6 million people in Europe (Linehan et al, 2021), and over 50 million globally (WHO, 2020), and is considered to be one of the leading causes of disability (Linehan et al, 2021). Administration of…
March 28, 2022
Applications of BrainPET for Major Depressive Disorder
Vedashree Meher, M.Sc Major depressive disorder (MDD) is diagnosed when an individual consistently feels low, has a depressed mood, takes lack of pleasure in activities, experiences feeling of worthlessness, has lack of energy, poor concentration, sleep deprivation, decreased appetite and/or suicidal ideation (Bains & Abdijadid, 2022). To be diagnosed with MDD, individuals have to present…
February 9, 2022
Brain PET imaging of stroke
Vedashree Meher, M.Sc Stroke is a clinical syndrome, so-named due to the sudden onset of symptoms caused by reduced blood supply, oxygen and nutrients to the brain. Stroke is a second leading cause of death and a major contributor of long-term disabilities globally (Katan & Luft, 2018). There are two types of strokes: hemorrhagic and…
January 6, 2022
Brain PET imaging of schizophrenia
Vedashree Meher, M.Sc. Schizophrenia is a psychiatric illness that affects how a person thinks, feels and behaves. Schizophrenia can present as positive symptoms or negative symptoms. Positive symptoms include delusions, hallucinations and disorganized speech whereas, negative symptoms include apathy, lack of motivation and anhedonia (lack of pleasure) (Patel et al., 2014). In order to be…
November 26, 2021
Artificial Intelligence and PET/MRI
Artificial Intelligence and PET/MRIManjari Murthy, Director of Product Management Artificial intelligence, or AI, is one of buzziest topics in medicine. AI in medicine is a blanket term to describe computer programs that use machine learning to improve doctors’ ability assess medical data with the goal of improving health outcomes. This can be in the form…
October 8, 2021
Mental Illness and Brain PET/MRI
Mental Illness and Brain PET/MRIManjari Murthy, Director of Product Management October 10th is World Mental Health Day, an international event in recognition and support of the millions of people worldwide suffering from a range of illnesses that are pervasive, yet still poorly understood. Initiatives to improve the visibility of mental illness have led to increases…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information